
### [NCIT:C6919](http://purl.obolibrary.org/obo/NCIT_C6919)
**Label:** T Lymphoblastic Lymphoma

**Subclasses:** [NCIT:C7227](http://purl.obolibrary.org/obo/NCIT_C7227) (Refractory T Lymphoblastic Lymphoma), [NCIT:C7226](http://purl.obolibrary.org/obo/NCIT_C7226) (Adult T Lymphoblastic Lymphoma), [NCIT:C7311](http://purl.obolibrary.org/obo/NCIT_C7311) (Splenic T Lymphoblastic Lymphoma), [NCIT:C7210](http://purl.obolibrary.org/obo/NCIT_C7210) (Childhood T Lymphoblastic Lymphoma), 

**Class expressions from DL-Learner:**

- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C39620](http://purl.obolibrary.org/obo/NCIT_C39620) (Dermatopathic Lymphadenopathy))) 57.14%
- Thing 52.15%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 47.21%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 46.18%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) 42.50%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C3998](http://purl.obolibrary.org/obo/NCIT_C3998) (Recurrent Colon Carcinoma))) 42.50%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C39966](http://purl.obolibrary.org/obo/NCIT_C39966) (Ovarian Sertoli-Stromal Cell Tumor))) 42.50%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C39963](http://purl.obolibrary.org/obo/NCIT_C39963) (Penile Bowenoid Papulosis))) 42.50%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C39961](http://purl.obolibrary.org/obo/NCIT_C39961) (Penile Basal Cell Carcinoma))) 42.50%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C39959](http://purl.obolibrary.org/obo/NCIT_C39959) (Mixed Squamous Cell Carcinoma of the Penis))) 42.50%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C39957](http://purl.obolibrary.org/obo/NCIT_C39957) (Epididymal Adenocarcinoma))) 42.50%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C39956](http://purl.obolibrary.org/obo/NCIT_C39956) (Rete Testis Adenoma))) 42.50%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C3994](http://purl.obolibrary.org/obo/NCIT_C3994) (Stage IV Colon Cancer AJCC v6))) 42.50%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C3993](http://purl.obolibrary.org/obo/NCIT_C3993) (Stage II Colon Cancer AJCC v6))) 42.50%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C39914](http://purl.obolibrary.org/obo/NCIT_C39914) (Gain of Chromosome 12p))) 42.50%


